The Catalyst Brief
Coverage

AI in Drug Discovery

Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.

Page 3 of 6

Archive

Healthcare AI’s Next Frontier: Enhancing Patient Comprehension in RadiologyMay 29, 2026

Healthcare AI’s Next Frontier: Enhancing Patient Comprehension in Radiology

The application of artificial intelligence in healthcare continues to evolve, particularly in radiology, where AI technologies are revolutionizing image analysis. Beyond diagnostics, the introduction of a patient comprehension layer powered by AI has the potential to facilitate clearer communication of complex medical information.

Jonathan BlakeJonathan Blake
Employers are Scaling AI Use in Health Benefits, but Face ChallengesMay 27, 2026

Employers are Scaling AI Use in Health Benefits, but Face Challenges

Amid a growing interest and rapid adoption of artificial intelligence in health benefits administration, employers are confronted with pivotal concerns that could affect the sustainable integration of AI technologies. This post explores the dynamics of this transformation, the results of a recent WTW survey, and the challenges impacting both employers and employees.

Jonathan BlakeJonathan Blake
Artificial Intelligence Advancing Rare Disease Treatment and Healthcare InnovationMay 20, 2026

Artificial Intelligence Advancing Rare Disease Treatment and Healthcare Innovation

The use of artificial intelligence in healthcare is expanding rapidly, with recent examples highlighting its role in uncovering treatments for ultra-rare diseases and enhancing healthcare delivery through innovative AI tools. These advancements reflect AI’s growing capability to address complex medical challenges and improve patient care.

Sophia ReynoldsSophia Reynolds
IKS Health Acquires ARAI to Build Out Specialized AI StackMay 16, 2026

IKS Health Acquires ARAI to Build Out Specialized AI Stack

The acquisition reflects a growing trend in healthcare automation where companies seek to build proprietary and specialized AI technology to streamline operations and improve service delivery. This move by IKS Health is aimed at consolidating their technological backbone to better support the healthcare sector’s evolving demands.

Dr. Alex MorganDr. Alex Morgan
Building Trust: The Path to AI Integration in Physical TherapyMay 6, 2026

Building Trust: The Path to AI Integration in Physical Therapy

As artificial intelligence continues to advance within healthcare, physical therapists explore how to incorporate AI effectively and ethically into musculoskeletal (MSK) care. Establishing trust in these technologies and implementing clear operational rules are critical for successful integration.

Emily CarterEmily Carter
What Will Separate Healthcare AI Winners From Losers?Apr 5, 2026

What Will Separate Healthcare AI Winners From Losers?

Industry experts suggest that the future leaders in healthcare AI will be distinguished by their ability to embed their technology within existing medical environments, leverage unique data assets, and effectively navigate commercialization challenges. This analysis delves into the key factors that could determine winners and losers in the evolving healthcare AI landscape.

Jonathan BlakeJonathan Blake
Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral HealthApr 1, 2026

Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health

The infusion of $17 million from investors including M13 and Town Hall Ventures will enable Jimini Health to scale its AI platform Sage, which integrates clinician supervision to provide complex mental health care. This development marks a significant step in AI-driven behavioral health solutions.

Michael TorresMichael Torres
How Mass General Brigham Evaluates and Scales AI Tools in HealthcareMar 31, 2026

How Mass General Brigham Evaluates and Scales AI Tools in Healthcare

Mass General Brigham has established a rigorous process for deciding which artificial intelligence tools are worth deploying across their health system. This careful evaluation aims to balance innovation with patient safety and operational effectiveness.

Daniel ChoDaniel Cho

Other beats

Biopharmaceutical Industry

Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.

Biotech Innovation

Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.

Healthcare Investment

Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.

Medical Technology

Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.

Regulatory & Policy

FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.